Advisor Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Advisor Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,632	Closed	-$51K	–	5195
2018 Q1	$51K	Sell	2,632 -25	-0.9%	-$491	﹤0.01%	3059
2017 Q4	$44K	Buy	2,657 +2,460	+1,249%	+$45.1K	﹤0.01%	3175
2017 Q3	$4K	Sell	197 -28	-12%	-$535	﹤0.01%	4399
2017 Q2	$4K	Sell	225 -160	-42%	-$2.36K	﹤0.01%	4372
2017 Q1	$5K	Sell	385 -5	-1%	-$60	﹤0.01%	4159
2016 Q4	$5K	Hold	390	–	–	﹤0.01%	3976
2016 Q3	$9K	Sell	390 -42	-10%	-$1.13K	﹤0.01%	3652
2016 Q2	$11K	Buy	+432	New	+$14.1K	﹤0.01%	3458

Advisor Group's IPXL Position: Q2 2018 in Review

Advisor Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 2,632 shares — an estimated $51K sold.

Advisor Group first reported a position in IPXL in Q2 2016 and held it in 8 quarters. The position peaked at $51K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Advisor Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Advisor Group sold 2,632 Impax Laboratories, Inc. shares in Q2 2018, an estimated $51K.
Advisor Group first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 8 quarters.
Advisor Group's Impax Laboratories, Inc. position peaked at $51K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Advisor Group's 13F filing for Q2 2018, filed 13 Aug 2018.